← SynDRA
PARCETASAL
SynDRA canonical compound SYN0031361 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MT-CO1 | MT-CO2 |
| Mechanism of action | anti-inflammatory agent |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- MR-897
- N-[4-(2-Methyl-4-oxo-1,3-benzodioxan-2-yloxy)phenyl]acetamide
- Rac-4'-(2-Methyl-4-oxo-1,3-benzodioxan-2-yloxy)acetanilide
- Parcetasal [INN]
- Parcetasalum
- Parcetasalum [INN-Latin]
- UNII-3LSZ7869T2
- 3LSZ7869T2
- PARCETASAL [WHO-DD]
- Parcetasalum (INN-Latin)
- RefChem:170051
- MR 897
- SCHEMBL379733
- orb1309281
- SCHEMBL29454391
- MDA54936
- HY-U00100
- MFCD00866092
- AKOS040733957
- CS-7136
- DA-76596
- MS-24574
- NS00127119
- F81806
- T12361
- F979522
Look up PARCETASAL in the interactive SynDRA portal →